| http://www.w3.org/ns/prov#value | - Routine monitoring of calculated creatinine clearance and serum phosphorus should be performed in patients at risk for renal impairment, including patients who have previously experienced renal events while receiving HEPSERA.Atripla () should be avoided with concurrent or recent use of a nephrotoxic agent.
|
